APPLICATION
ANDA215550
TYPE
ANDA
ORIGINAL APPROVAL
2023-12-26
LATEST ACTION
2023-12-26
ROUTE
OPHTHALMIC
DOSAGE FORM
SUSPENSION/DROPS
MARKETING STATUS
Prescription
Products
LOTEPREDNOL ETABONATEPrescription
LOTEPREDNOL ETABONATE 0.2% · SUSPENSION/DROPS · OPHTHALMIC
Approval history
2023-12-26UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.